Close
ACHEMA MIDDLE EAST 2026

Omicron Subvariants Withstand Essential Antibody Treatments

The White House issued a warning this week that HIV patients, kidney transplant recipients, and other immunocompromised people are particularly susceptible to COVID this...

Research And Development In UK Falls Behind Other Nations

According to a new report by IPPR, the UK's percentage of worldwide research and development (R&D) spending has decreased by 5% since 2014. Even...

FDA Under Strain To Amend The Accelerated Approval Program

The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by the protracted, complicated FDA process to discontinue commercialization of...

Prostate Cancer Screening Rates Lower With Advanced Cancers

According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate cancer screening has been associated with a subsequent rise...

ICR Researchers Examine How New Medications Affect Cancer

Researchers discovered that by turning off the function of two genes, stomach tumours can become resistant to ATR inhibitors. As a result, genetic screening...

NHS To Provide Brain Laser Therapy To Those With Epilepsy

The NHS has made public its intentions to provide an avant-garde laser therapy for patients with epilepsy who have not previously responded well to...

HIV Patients Avoid hepatitis B With A Three-Dose Vaccine

A three-dose series of the HEPLISAV-B vaccine protects against hepatitis B virus (HBV) in HIV patients who have not received a prior vaccination against...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...